These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19027874)

  • 1. Modelling iterative compound optimisation using a self-avoiding walk.
    Delaney J
    Drug Discov Today; 2009 Feb; 14(3-4):198-207. PubMed ID: 19027874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of a virtual lab in drug discovery.
    Rauwerda H; Roos M; Hertzberger BO; Breit TM
    Drug Discov Today; 2006 Mar; 11(5-6):228-36. PubMed ID: 16580600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research & market strategy: how choice of drug discovery approach can affect market position.
    Sams-Dodd F
    Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative risk modelling for new pharmaceutical compounds.
    Tang Z; Taylor MJ; Lisboa P; Dyas M
    Drug Discov Today; 2005 Nov; 10(22):1520-6. PubMed ID: 16257374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connecting the dots: role of standardization and technology sharing in biological simulation.
    Ghosh S; Matsuoka Y; Kitano H
    Drug Discov Today; 2010 Dec; 15(23-24):1024-31. PubMed ID: 20934535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular automata model for swelling-controlled drug release.
    Laaksonen H; Hirvonen J; Laaksonen T
    Int J Pharm; 2009 Oct; 380(1-2):25-32. PubMed ID: 19563871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive biosimulation and virtual patients in pharmaceutical R and D.
    Bangs A
    Stud Health Technol Inform; 2005; 111():37-42. PubMed ID: 15718695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.
    Läer S; Barrett JS; Meibohm B
    J Clin Pharmacol; 2009 Aug; 49(8):889-904. PubMed ID: 19531673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling and analysis of the sugar cataract development process using stochastic hybrid systems.
    Riley D; Koutsoukos X; Riley K
    IET Syst Biol; 2009 May; 3(3):137-54. PubMed ID: 19449975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling approaches for bio-manufacturing operations.
    Chhatre S
    Adv Biochem Eng Biotechnol; 2013; 132():85-107. PubMed ID: 23183689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A priori performance predictions in the pharmaceutical sciences.
    Hancock BC; Morris KR; Wildfong PL
    Int J Pharm; 2011 Oct; 418(2):149-50. PubMed ID: 21726614
    [No Abstract]   [Full Text] [Related]  

  • 13. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    Beaumont K; Smith DA
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing compound subsets: comparison of random and rational approaches using statistical simulation.
    Yeap SK; Walley RJ; Snarey M; van Hoorn WP; Mason JS
    J Chem Inf Model; 2007; 47(6):2149-58. PubMed ID: 17918926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of surrogate modelling for multiobjective optimisation of urban wastewater systems.
    Fu G; Khu ST; Butler D
    Water Sci Technol; 2009; 60(6):1641-7. PubMed ID: 19759467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A point process driven multiple change point model: a robust resistant approach.
    Arunajadai SG
    Math Biosci; 2009 Jul; 220(1):57-71. PubMed ID: 19409918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations and theory of protein translocation.
    Makarov DE
    Acc Chem Res; 2009 Feb; 42(2):281-9. PubMed ID: 19072704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.